Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 20
1976 47
1977 57
1978 43
1979 65
1980 39
1981 59
1982 49
1983 42
1984 44
1985 63
1986 73
1987 67
1988 47
1989 56
1990 61
1991 65
1992 56
1993 64
1994 48
1995 49
1996 55
1997 46
1998 53
1999 57
2000 36
2001 58
2002 60
2003 48
2004 51
2005 50
2006 69
2007 58
2008 72
2009 59
2010 58
2011 65
2012 58
2013 65
2014 81
2015 65
2016 68
2017 81
2018 66
2019 69
2020 48
2021 55
2022 47
2023 42
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

2,627 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
Ehrmann S, Barbier F, Demiselle J, Quenot JP, Herbrecht JE, Roux D, Lacherade JC, Landais M, Seguin P, Schnell D, Veinstein A, Gouin P, Lasocki S, Lu Q, Beduneau G, Ferrandiere M, Plantefève G, Dahyot-Fizelier C, Chebib N, Mercier E, Heuzé-Vourc'h N, Respaud R, Gregoire N, Garot D, Nay MA, Meziani F, Andreu P, Clere-Jehl R, Zucman N, Azaïs MA, Saint-Martin M, Gandonnière CS, Benzekri D, Merdji H, Tavernier E; Reva and CRICS-TRIGGERSEP F-CRIN Research Networks. Ehrmann S, et al. N Engl J Med. 2023 Nov 30;389(22):2052-2062. doi: 10.1056/NEJMoa2310307. Epub 2023 Oct 25. N Engl J Med. 2023. PMID: 37888914 Clinical Trial.
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Griffith DE, et al. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC. Am J Respir Crit Care Med. 2018. PMID: 30216086 Clinical Trial.
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.
Jenkins A, Thomson AH, Brown NM, Semple Y, Sluman C, MacGowan A, Lovering AM, Wiffen PJ; (BSAC Working Party on Therapeutic Drug Monitoring). Jenkins A, et al. J Antimicrob Chemother. 2016 Oct;71(10):2754-9. doi: 10.1093/jac/dkw250. Epub 2016 Jul 11. J Antimicrob Chemother. 2016. PMID: 27494904 Free article. Review.
Inhaled liposomal amikacin.
Waters V, Ratjen F. Waters V, et al. Expert Rev Respir Med. 2014 Aug;8(4):401-9. doi: 10.1586/17476348.2014.918507. Epub 2014 May 31. Expert Rev Respir Med. 2014. PMID: 24882271 Review.
Amikacin.
[No authors listed] [No authors listed] Lancet. 1977 Apr 23;1(8017):891. Lancet. 1977. PMID: 67295 No abstract available.
Amikacin.
Meyer RD. Meyer RD. Ann Intern Med. 1981 Sep;95(3):328-32. doi: 10.7326/0003-4819-95-3-328. Ann Intern Med. 1981. PMID: 7023310 Review. No abstract available.
Amikacin retinal toxicity.
Jackson TL, Williamson TH. Jackson TL, et al. Br J Ophthalmol. 1999 Oct;83(10):1199-200. doi: 10.1136/bjo.83.10.1194f. Br J Ophthalmol. 1999. PMID: 10636651 Free PMC article. No abstract available.
2,627 results